Quantcast
Last updated on April 16, 2014 at 13:39 EDT

Latest Chronic kidney disease Stories

2013-03-22 15:16:08

Tests of resistance could help doctors monitor and treat patients Highlights: -Suboptimal kidney response to the hormone FGF-23 may put chronic kidney disease patients at increased risk of premature death and cardiovascular events. -Resistance to the hormonal actions of FGF-23 in the kidney may identify novel aspects of kidney dysfunction. -60 million people globally have chronic kidney disease. The kidneys' response to a particular hormone may affect kidney disease patients' heart...

2013-03-20 15:43:43

Risk remains elevated for 2 years after initiation Research: Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases Editorial: Statins in acute kidney injury: friend or foe? Patients taking high potency statins for high blood pressure are at a 34% higher risk of being hospitalized for acute kidney injury (AKI), compared with those taking low potency statins, a paper published today on...

2013-03-20 08:26:48

Patients ask Centers for Medicare and Medicaid Services (CMS) to provide adequate reimbursement for up-front training costs to make HHD more accessible to Medicare patients WASHINGTON, March 20, 2013 /PRNewswire/ -- In honor of National Kidney Month, current and former dialyzors with Hemodialysis at Home: A Better Way for a Better Life , a NxStage Medical, Inc. (NASDAQ: NXTM) sponsored project, gathered in Washington, D.C. today to urge the Centers for Medicare and Medicaid Services...

2013-03-19 12:27:48

March "Summit" Aims to Identify Quality Improvement Goals and Develop Recommendations for Medicare's Quality Incentive Program WASHINGTON, March 19, 2013 /PRNewswire-USNewswire/ -- Kidney Care Partners - the nation's largest kidney care coalition consisting of patient advocates, dialysis professionals, care providers, researchers and manufacturers dedicated to working together to improve quality of care for individuals with end-stage and chronic kidney disease - announced plans to...

2013-03-19 08:26:46

Formation of American Alliance Dialysis Holdings, LLC in Partnership With Dr. Randall Maxey, Dr. Otegbola Ojo, and Ms. Ruby Harford Will Acquire and Build Operations in North America and the Caribbean NEW YORK, March 19, 2013 /PRNewswire/ -- ICV Partners (ICV), a leading investment firm focused on lower middle market companies, announced today that it has established a kidney dialysis treatment platform with the acquisition of Atlantis Healthcare Group Puerto Rico, Inc. ("Atlantis"),...

2013-03-18 08:28:32

-- Actively Recruiting for Neo-Urinary Conduit(TM) Phase 1 Trial -- WINSTON-SALEM, N.C., March 18, 2013 /PRNewswire/ -- Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today reported its financial results for the fourth quarter and full year ended December 31, 2012 and provided a business update. "Over the last year we made continued progress in our Phase 1 trial for the Neo-Urinary Conduit. We have initially demonstrated that urinary tissue can be regenerated in...

2013-03-14 16:24:40

HARRISBURG, Pa., March 14, 2013 /PRNewswire-USNewswire/ -- The Pennsylvania Department of Health, along with the National Kidney Foundation and the Kidney Foundation of Central Pennsylvania, gave free kidney screenings today in Harrisburg. A total of nine organizations participated in the event, arranged for World Kidney Day. Visitors to the event were given information and educational materials, free blood pressure screenings and kidney health risk assessments. In addition, a pharmacist...

2013-03-14 12:28:48

Public Encouraged to Learn About Their Kidneys and Understand Their Risks on World Kidney Day, March 14, 2013 MADISON, N.J., March 14, 2013 /PRNewswire/ -- On World Kidney Day, Quest Diagnostics, the world's leading provider of diagnostic information services, today announced its support of the updated global version of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF-KDOQI) Chronic Kidney Disease (CKD) guideline recently released by Kidney Disease:...

2013-03-14 08:29:08

Presentation Scheduled for Monday, March 18th at 10:00 AM PT NEW YORK, March 14, 2013 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Ron Bentsur, the Company's Chief Executive Officer, will be presenting at the upcoming 25th Annual ROTH Conference, to be held March 17(th) -20(th) in Dana Point, California. Mr. Bentsur's presentation is scheduled to take place on Monday, March 18(th), at 10:00 AM PT (1:00 PM ET). A live audio webcast of Mr....

2013-03-13 08:34:02

NEW YORK, March 13, 2013 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of renal disease (the "Company"), today announced the appointment of Amit Sharma, M.D. to the newly created position of Vice President, Medical Affairs. Amit Sharma, M.D., is an accomplished board certified nephrologist, internist, and hypertension...